Amerah Amin

Amerah Amin is a seasoned professional in health economics and market access with extensive experience in the pharmaceutical industry. Currently serving as the Senior Director of Global Market Access and Pricing for Oncology at EMD Serono, Inc. since January 2024, Amerah previously held multiple roles at Merck Group, including Director of Market Access, Pricing, Government and Public Affairs for the UK and ROI. Earlier career highlights include positions at DHelix Group, OptumInsight, and Celgene, where Amerah gained substantial expertise in health economics and outcomes research. Amerah's academic background includes an MSc in International Health Policy (Health Economics) from the London School of Economics and an MSc in Pharmacy from the School of Pharmacy, University of London.